Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Environ Microbiol ; 90(4): e0223423, 2024 Apr 17.
Article in English | MEDLINE | ID: mdl-38497641

ABSTRACT

The primary objective of this study was to identify associations between the prepartum teat apex microbiome and the presence of Staphylococcus aureus intramammary infections (IMI) in primiparous cows during the first 5 weeks after calving. We performed a case-control study using shotgun metagenomics of the teat apex and culture-based milk data collected longitudinally from 710 primiparous cows on five organic dairy farms. Cases had higher odds of having S. aureus metagenomic DNA on the teat apex prior to parturition compared to controls (OR = 38.9, 95% CI: 14.84-102.21). Differential abundance analysis confirmed this association, with cases having a 23.8 higher log fold change (LFC) in the abundance of S. aureus in their samples compared to controls. Of the most prevalent microorganisms in controls, those associated with a lower risk of post-calving S. aureus IMI included Microbacterium phage Min 1 (OR = 0.37, 95% CI: 0.25-0.53), Corynebacterium efficiens (OR = 0.53, 95% CI: 0.30-0.94), Kocuria polaris (OR = 0.54, 95% CI: 0.35-0.82), Micrococcus terreus (OR = 0.64, 95% CI: 0.44-0.93), and Dietzia alimentaria (OR = 0.45, 95% CI: 0.26-0.75). Genes encoding for Microcin B17 AMPs were the most prevalent on the teat apex of cases and controls (99.7% in both groups). The predicted abundance of genes encoding for Microcin B17 was also higher in cases compared to controls (LFC 0.26). IMPORTANCE: Intramammary infections (IMI) caused by Staphylococcus aureus remain an important problem for the dairy industry. The microbiome on the external skin of the teat apex may play a role in mitigating S. aureus IMI risk, in particular the production of antimicrobial peptides (AMPs) by commensal microbes. However, current studies of the teat apex microbiome utilize a 16S approach, which precludes the detection of genomic features such as genes that encode for AMPs. Therefore, further research using a shotgun metagenomic approach is needed to understand what role prepartum teat apex microbiome dynamics play in IMI risk.


Subject(s)
Mastitis, Bovine , Staphylococcal Infections , Female , Cattle , Animals , Staphylococcus aureus/genetics , Metagenome , Case-Control Studies , Mastitis, Bovine/epidemiology , Mastitis, Bovine/microbiology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/veterinary , Staphylococcal Infections/microbiology , Milk/microbiology , Mammary Glands, Animal/microbiology
2.
South Med J ; 90(4): 402-4, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9114831

ABSTRACT

It remains unclear whether preoperative mammograms are necessary in young patients having nononcologic breast surgery. Various authors have recommended mammography in all such cases, in conflict with guidelines from the American Cancer Society. We conducted a retrospective study to determine the utility of preoperative mammograms in young women. From 1989 through 1994, 208 patients under 35 years of age had elective breast surgery in our institution. Fifty-one (24.5%) had preoperative mammography. No malignancies were diagnosed. We believe mammograms are not routinely needed before elective breast surgery in patients under 35 years of age.


Subject(s)
Mammaplasty , Mammography , Adolescent , Adult , Female , Humans , Predictive Value of Tests , Preoperative Care
3.
Mich Health Hosp ; 31(5): 16-7, 1995.
Article in English | MEDLINE | ID: mdl-10151695

ABSTRACT

Lobbying by tax-exempt entities is permissible, but regulated by the Internal Revenue Code. Tax-exempt entities that lobby should not be confused with political activity by tax-exempt entities. Although a public charity may not involve itself in political campaign activities in any way, a public charity may engage in a certain level of lobbying activities. Consider three hypothetical situations involving CEOs of health care providers.


Subject(s)
Charities/legislation & jurisprudence , Lobbying , Politics , Taxes/legislation & jurisprudence , Charities/economics , Health Facility Administrators/legislation & jurisprudence , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...